Filing metadata

Accession number
0000950170-24-110373
Form type
Form 4
Filer
Apellis Pharmaceuticals, Inc.
CIK
CIK 1492422
Filed
Sep 30, 2024
Reporting period
Sep 27, 2024
Description
Insider transaction

Explore SEC Filings Hub